IBDEI1H3 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23825,1,3,0)
 ;;=3^Breast Lump,Right,Lower Outer Quadrant
 ;;^UTILITY(U,$J,358.3,23825,1,4,0)
 ;;=4^N63.13
 ;;^UTILITY(U,$J,358.3,23825,2)
 ;;=^5151522
 ;;^UTILITY(U,$J,358.3,23826,0)
 ;;=N63.10^^82^1032^36
 ;;^UTILITY(U,$J,358.3,23826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23826,1,3,0)
 ;;=3^Breast Lump,Right,Unsp Quadrant
 ;;^UTILITY(U,$J,358.3,23826,1,4,0)
 ;;=4^N63.10
 ;;^UTILITY(U,$J,358.3,23826,2)
 ;;=^5151519
 ;;^UTILITY(U,$J,358.3,23827,0)
 ;;=N63.12^^82^1032^37
 ;;^UTILITY(U,$J,358.3,23827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23827,1,3,0)
 ;;=3^Breast Lump,Right,Upper Inner Quadrant
 ;;^UTILITY(U,$J,358.3,23827,1,4,0)
 ;;=4^N63.12
 ;;^UTILITY(U,$J,358.3,23827,2)
 ;;=^5151521
 ;;^UTILITY(U,$J,358.3,23828,0)
 ;;=N63.11^^82^1032^38
 ;;^UTILITY(U,$J,358.3,23828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23828,1,3,0)
 ;;=3^Breast Lump,Right,Upper Outer Quadrant
 ;;^UTILITY(U,$J,358.3,23828,1,4,0)
 ;;=4^N63.11
 ;;^UTILITY(U,$J,358.3,23828,2)
 ;;=^5151520
 ;;^UTILITY(U,$J,358.3,23829,0)
 ;;=N63.41^^82^1032^35
 ;;^UTILITY(U,$J,358.3,23829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23829,1,3,0)
 ;;=3^Breast Lump,Right,Subareolar
 ;;^UTILITY(U,$J,358.3,23829,1,4,0)
 ;;=4^N63.41
 ;;^UTILITY(U,$J,358.3,23829,2)
 ;;=^5151531
 ;;^UTILITY(U,$J,358.3,23830,0)
 ;;=N63.15^^82^1032^34
 ;;^UTILITY(U,$J,358.3,23830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23830,1,3,0)
 ;;=3^Breast Lump,Right,Overlapping Quadrants,Unspec
 ;;^UTILITY(U,$J,358.3,23830,1,4,0)
 ;;=4^N63.15
 ;;^UTILITY(U,$J,358.3,23830,2)
 ;;=^5158108
 ;;^UTILITY(U,$J,358.3,23831,0)
 ;;=N63.25^^82^1032^26
 ;;^UTILITY(U,$J,358.3,23831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23831,1,3,0)
 ;;=3^Breast Lump,Left,Overlapping Quadrants,Unspec
 ;;^UTILITY(U,$J,358.3,23831,1,4,0)
 ;;=4^N63.25
 ;;^UTILITY(U,$J,358.3,23831,2)
 ;;=^5158109
 ;;^UTILITY(U,$J,358.3,23832,0)
 ;;=N99.85^^82^1032^112
 ;;^UTILITY(U,$J,358.3,23832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23832,1,3,0)
 ;;=3^Post Endometrial Ablation Syndrome
 ;;^UTILITY(U,$J,358.3,23832,1,4,0)
 ;;=4^N99.85
 ;;^UTILITY(U,$J,358.3,23832,2)
 ;;=^5158110
 ;;^UTILITY(U,$J,358.3,23833,0)
 ;;=Z86.002^^82^1032^109
 ;;^UTILITY(U,$J,358.3,23833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23833,1,3,0)
 ;;=3^Personal Hx In-Situ Neop,Other/Unspec Genital Organs
 ;;^UTILITY(U,$J,358.3,23833,1,4,0)
 ;;=4^Z86.002
 ;;^UTILITY(U,$J,358.3,23833,2)
 ;;=^5158325
 ;;^UTILITY(U,$J,358.3,23834,0)
 ;;=I05.8^^82^1033^29
 ;;^UTILITY(U,$J,358.3,23834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23834,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,23834,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,23834,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,23835,0)
 ;;=I10.^^82^1033^18
 ;;^UTILITY(U,$J,358.3,23835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23835,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,23835,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,23835,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,23836,0)
 ;;=I25.2^^82^1033^27
 ;;^UTILITY(U,$J,358.3,23836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23836,1,3,0)
 ;;=3^Old MI
 ;;^UTILITY(U,$J,358.3,23836,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,23836,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,23837,0)
 ;;=I25.10^^82^1033^3
 ;;^UTILITY(U,$J,358.3,23837,1,0)
 ;;=^358.31IA^4^2
